Los Angeles Talc Bellwether Verdict: What a Defense Verdict for Johnson & Johnson Really Means for Your Ovarian Cancer Claim
If you are reading this because someone you love used Johnson & Johnson baby powder for years — maybe decades — and then developed ovarian cancer, and you just saw the headline that a Los Angeles jury found J&J not liable after a six-week trial, stop. Take a breath. That verdict is not the end of your case. It is not the end of talc litigation. And it is not the end of accountability for the families who lost mothers, wives, sisters, and daughters to a disease that may have been caused by a product marketed to them since they were children.
We are Attorney911 — The Manginello Law Firm, PLLC. We are toxic tort and product liability attorneys who take California cases, and we built this page because the single most dangerous thing about a defense verdict in a bellwether trial is not the verdict itself — it is the silence that follows it. Families read the headline, assume their case is dead, and never call a lawyer. The statute of limitations clock keeps running. The evidence keeps disappearing. And the company that just won gets exactly what it wanted: fewer claims, less pressure, and more time.
So here is the first thing you need to hear: in December, in the first California bellwether trial in this same coordinated proceeding, a different jury looked at the same company, the same product, the same science — and returned a $40 million verdict against Johnson & Johnson. Two trials. Same courthouse system. Same claims. One produced $40 million for the plaintiffs. The other produced a defense verdict. That is not a contradiction. That is how bellwether trials work. And understanding why is the difference between walking away from a valid claim and fighting it.
What This Defense Verdict Actually Means — and What It Does Not Mean
A defense verdict means that one specific jury, hearing one specific set of three plaintiffs’ cases, was not persuaded that Johnson & Johnson’s baby powder caused those three women’s ovarian cancer. It means the defense team — some of the most expensive lawyers in the country — successfully raised enough doubt about causation that the jurors could not say, by the required burden of proof, that talc was the cause.
It does not mean the science was rejected. It does not mean the product is safe. It does not mean the $40 million verdict from the first bellwether was wrong. And it does not mean your case — with your loved one’s specific exposure history, your specific medical records, your specific pathology slides — would produce the same result.
What it does mean is that the defense has identified its strongest argument and will keep using it: specific causation. That is the fight this verdict reveals, and it is the fight every future talc case must win.
The Bellwether Process: Why One Verdict Does Not End a Mass Tort
A bellwether trial is a test case. When a mass tort produces thousands of claims — and the national talc-ovarian cancer docket has tens of thousands — the court cannot try them all. So the parties select a small number of representative cases to try first. These are the “bellwethers,” and their purpose is diagnostic: they test the evidence, the expert testimony, the jury reception, and the defense strategy in real courtroom conditions before the court and the parties decide how to resolve the remaining thousands of cases.
The critical word is diagnostic. Bellwether verdicts are not binding precedent. They do not determine the outcome of any other plaintiff’s case. They inform strategy — for both sides. A plaintiff verdict tells the defense that juries can be persuaded and that settlement pressure will increase. A defense verdict tells the defense that its causation arguments can work and that it should try more cases before negotiating a global resolution.
In the California coordinated talc proceeding, the first bellwether produced a $40 million plaintiff verdict. The second produced a defense verdict. This split is not unusual in mass tort bellwethers. In the national hernia mesh MDL, the first bellwether was a defense verdict and the next two were plaintiff verdicts. In the Roundup litigation, some trials produced large plaintiff verdicts while others produced defense outcomes. The pattern is the point: bellwethers are experiments, and experiments produce variable results.
Here is what the split between the two California bellwethers tells us about the road ahead:
| First California Bellwether (December) | Second California Bellwether (This Trial) |
|---|---|
| Jury found J&J liable | Jury found J&J not liable |
| $40 million verdict | Defense verdict ($0) |
| Plaintiffs prevailed on causation | Defense prevailed on causation |
| Same coordinated proceeding | Same coordinated proceeding |
| Same product, same claims, same courthouse system | Same product, same claims, same courthouse system |
Two juries, hearing the same type of case in the same court system, reached opposite conclusions. That is the bellwether process working exactly as designed — testing whether the evidence persuades real jurors, and where the weak points are.
The Causation Battleground: General Causation vs. Specific Causation
This is the heart of every talc-ovarian cancer case, and the defense verdict in the second bellwether tells us exactly where the defense won and where plaintiffs must improve.
There are two layers of causation in a toxic tort product liability case, and both must be proven:
General causation asks: Can talc cause ovarian cancer in humans? This is a question about the scientific literature — the epidemiological studies, the biological mechanism theories, the toxicology, the meta-analyses. It is about whether the association between perineal talc use and ovarian cancer is real and biologically plausible, not whether it caused one specific person’s cancer. General causation in talc cases is supported by decades of epidemiological research, including studies showing a statistically significant association between long-term perineal talc use and ovarian cancer, and biological mechanism theories describing how talc particles could travel from the perineum through the reproductive tract to the ovaries, causing chronic inflammation and, over time, carcinogenesis.
Specific causation asks: Did talc use cause this plaintiff’s ovarian cancer? This is an individual question. It requires proof that the specific decedent used the product in a way and for a duration that created meaningful exposure, that the exposure was sufficient to cause the disease, and that the disease was not more likely caused by something else.
The defense won the second bellwether on specific causation. Here is how:
The defense emphasizes alternative ovarian cancer risk factors — BRCA1 and BRCA2 genetic mutations, family history of ovarian or breast cancer, nulliparity (never having given birth), endometriosis, pelvic inflammatory disease, obesity, hormone replacement therapy, age, and reproductive history. Every woman has some combination of these factors, and the defense uses them to construct an alternative narrative: this cancer was not caused by talc; it was caused by genetics, or age, or reproductive history, or bad luck.
The defense also exploits the absence of a universally accepted biological mechanism. While epidemiological studies show an association between talc use and ovarian cancer, the precise biological pathway — exactly how talc particles travel to the ovaries, exactly how they cause cellular damage, exactly why that damage becomes cancer — has not been proven to the degree the defense demands. The defense argues that without a proven mechanism, the epidemiological association is just a correlation, not causation.
Future plaintiff strategies must invest heavily in specific causation experts — gynecologic oncologists who can testify about the decedent’s individual risk profile and explain why talc was the more likely cause; pathologists who can analyze preserved tumor tissue for mineral particles; mineralogists who can perform mineral analysis on tissue blocks to detect talc fibers in the ovarian tissue itself. The most powerful specific causation evidence is physical: if mineral analysis of the decedent’s preserved tumor tissue finds talc particles embedded in the ovarian tissue, that is direct, physical proof of exposure reaching the target organ. Not every case has preserved tissue — but when it does, it changes the entire causation fight.
California’s Product Liability Framework: Strict Liability, Barker, and Sargon
California is one of the strongest product liability jurisdictions in the country for plaintiffs, and understanding why requires knowing the specific doctrines that govern these cases.
Strict Products Liability Under Greenman and Barker
California was one of the first states to adopt strict products liability — the principle that a manufacturer is responsible for injuries caused by its defective product regardless of whether it was negligent. The foundational case is Greenman v. Yuba Power Products, which established that a manufacturer is strictly liable when a product is defective and causes injury while being used in a reasonably foreseeable way.
For design defect claims — which are central to talc cases — California uses the Barker v. Lull Engineering Co. dual test. Under Barker, a product is defective in design if either:
-
The consumer-expectation test: The product failed to perform as safely as an ordinary consumer would expect when used in an intended or reasonably foreseeable way. For talc, the argument is that an ordinary consumer would not expect a baby powder marketed for feminine hygiene to cause ovarian cancer.
-
The risk-benefit test: The benefits of the challenged design outweigh the risk of danger inherent in it. For talc, the argument is that the risk of ovarian cancer from perineal talc use outweighs the modest benefits of talc-based powder (especially given the availability of cornstarch-based alternatives).
A plaintiff can prevail under either prong. The consumer-expectation test is particularly powerful in talc cases because the product was marketed specifically for feminine hygiene use — the very use that allegedly caused the cancer. An ordinary consumer does not expect that a product marketed for personal hygiene will cause a fatal internal cancer decades later.
The Sargon Expert Standard
Expert testimony admissibility in California is governed by the Sargon standard (Evidence Code sections 801-802), which provides trial courts with a gatekeeping function comparable to but distinct from the federal Daubert standard, requiring that expert opinion be based on sound reasoning properly supported by the record.
This is critical in talc cases because both sides’ experts must survive the Sargon gatekeeping before they can testify. A well-qualified expert who can articulate a clear, biomechanically plausible pathway from perineal talc application through the reproductive tract to ovarian carcinogenesis — grounded in the epidemiological literature and the individual plaintiff’s exposure history — is essential. An expert whose methodology is weak or whose opinions are not tethered to the record will not survive Sargon, and without surviving experts, there is no case.
No MICRA Cap — No Statutory Limit on Damages
California imposes no statutory cap on non-economic damages in product liability actions — the MICRA cap applies exclusively to medical malpractice actions and does not extend to mass tort or product liability claims.
This is one of California’s most powerful advantages for talc plaintiffs. In medical malpractice cases, MICRA (the Medical Injury Compensation Reform Act) limits non-economic damages. But product liability cases — including talc-ovarian cancer wrongful death claims — are not subject to MICRA. There is no statutory ceiling on what a jury can award for the loss of love, companionship, comfort, care, affection, society, moral support, and guidance of a mother, wife, or sister. And there is no cap on punitive damages either.
Punitive Damages Under Civil Code Section 3294
Punitive damages are available in California product liability cases upon a showing of malice, oppression, or fraud by clear and convincing evidence. In the talc context, punitive damages theory typically relies on evidence that J&J knew or should have known of the association between perineal talc use and ovarian cancer based on epidemiological literature dating back decades, yet continued to market the product for feminine hygiene without adequate warnings. Internal corporate documents — testing records, safety analyses, scientific correspondence, and marketing decisions — are the evidence that supports punitive damages.
California’s Pure Comparative Negligence
California follows a pure comparative negligence system. Even if a plaintiff is found partly at fault, they can still recover — their damages are simply reduced by their percentage of fault. In product liability cases where the consumer used the product as directed and as marketed, contributory fault is rarely a significant factor. The manufacturer is responsible for foreseeable use — and marketing baby powder for feminine hygiene makes that use foreseeable by definition.
California’s Statute of Limitations and the Discovery Rule
California’s statute of limitations for personal injury and wrongful death claims generally runs two years under Code of Civil Procedure § 335.1. But in toxic tort and product liability cases involving latent diseases like ovarian cancer, California applies a discovery rule — the clock does not start when the exposure happened, but when the plaintiff knew or reasonably should have known of the injury and its cause.
For a talc-ovarian cancer case, the relevant date is not when the decedent first sprinkled powder decades ago. It is when the connection between talc and ovarian cancer was or should have been discovered — which may be the date of diagnosis, the date the plaintiff first learned of a possible link between talc and cancer, or a related date. For wrongful death claims, the two-year clock runs from the date of death, but the discovery rule can still affect when the underlying claim accrued.
This is not a guarantee that you have plenty of time. It is a reason to call a lawyer today rather than assuming you are too late — but also a reason not to wait, because the discovery rule has limits and the evidence is dying.
The Regulatory Gap: How Talc Reached Consumers Without FDA Warnings
One of the most important facts in any talc case is also one of the most frustrating: the federal regulatory system never required Johnson & Johnson to warn consumers that its baby powder might cause ovarian cancer.
The FDA regulates cosmetic products under the Federal Food, Drug, and Cosmetic Act, but cosmetic ingredients such as talc are not subject to premarket approval or specific safety monograph requirements, creating a regulatory gap that plaintiffs argue allowed a hazardous product to reach consumers without adequate federal scrutiny.
Unlike pharmaceutical products — which must go through rigorous FDA approval before reaching the market — cosmetic products like baby powder face no premarket safety review. The FDA does not test cosmetic ingredients for safety before they are sold. The FDA does not require safety data. The FDA does not approve labels for cosmetics the way it does for drugs. Talc, as a cosmetic ingredient, entered the market and stayed on the market for over a century without any federal agency ever reviewing whether perineal use was safe.
This regulatory gap matters for two reasons:
First, it means J&J cannot invoke federal preemption as a defense. Unlike pharmaceutical companies — which have successfully argued that FDA approval of a drug’s warning label preempts state-law failure-to-warn claims — cosmetic manufacturers like J&J cannot say “the federal government approved our label, so you cannot sue us for inadequate warnings.” The FDA never approved the label. The FDA never required a warning. The absence of a federal warning requirement means California state law on failure to warn applies in full.
Second, it means the absence of an FDA-mandated warning is not evidence that the product is safe. It is evidence that the regulatory system did not look. The FDA has conducted testing initiatives on cosmetic talc for asbestos contamination, but no binding federal regulation currently requires talc-specific carcinogenicity warnings on cosmetic products. California’s Proposition 65 — which requires warnings for chemicals known to the state to cause cancer — creates an additional layer of scrutiny, and the interplay between Prop 65 listing status and tort failure-to-warn claims is a recognized litigation vector in California product liability actions involving carcinogenic exposures.
Johnson & Johnson: The Corporate Structure and Litigation History
Johnson & Johnson is not a single company. It is a corporate family, and understanding its structure is essential to understanding both the litigation and the path to accountability.
The Corporate Family
Johnson & Johnson is the parent corporation — a New Jersey-based multinational with over $80 billion in annual revenue. The subsidiary that historically manufactured and sold baby powder is Johnson & Johnson Consumer Inc. (JJCI). In 2023, J&J spun off its consumer health business as Kenvue Inc. — a separate publicly traded company that now owns brands like Band-Aid, Tylenol, and Listerine. J&J retained the talc liability, and indemnity arrangements between J&J and Kenvue allocate the talc exposure back to J&J.
The Bankruptcy Strategy — Three Failed Attempts
J&J’s most revealing litigation strategy has been its repeated attempts to use bankruptcy to wall off talc liability. This is the “Texas two-step” — a maneuver where a company divides itself through a divisional merger, creating a new entity that holds all the liability, and then files that entity for Chapter 11 bankruptcy to force a global settlement through the bankruptcy court rather than the tort system.
J&J tried this three times:
First attempt: LTL Management LLC filed for Chapter 11 in 2021. The bankruptcy court dismissed it in 2023, finding the filing was not made in good faith because J&J was not in financial distress.
Second attempt: LTL Management LLC filed again with a revised strategy. The bankruptcy court dismissed it again.
Third attempt: Red River Talc LLC — a renamed successor liability vehicle — filed a prepackaged Chapter 11 in the Southern District of Texas. On March 31, 2025, the bankruptcy court (Judge Christopher Lopez) denied confirmation and dismissed the case, finding vote-solicitation irregularities and impermissible nonconsensual third-party releases.
Three attempts. Three dismissals. The cases are back in the tort system, where juries — not bankruptcy judges — decide what they are worth.
The National MDL Context
The federal multidistrict litigation — MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation — is consolidated in the U.S. District Court for the District of New Jersey before Judge Michael A. Shipp. As of June 2026, there were 68,029 actions pending in the federal MDL alone, with 70,712 total actions filed. That is in addition to the state-court coordinated proceedings in California and other states.
The largest verified talc verdict in U.S. history is Ingham v. Johnson & Johnson — a 2018 Missouri jury verdict of $4.69 billion for 22 plaintiffs. On appeal, the Missouri Court of Appeals reduced the award to approximately $2.12 billion. The U.S. Supreme Court denied certiorari on June 1, 2021, meaning the reduced award stands as final and affirmed. That is not a press release number — it is a number the highest court in the country let stand.
J&J Discontinued Talc-Based Baby Powder in North America
In 2023, J&J discontinued talc-based baby powder in the United States and Canada, replacing it with a cornstarch-based formula. The company cited “changing consumer habits” and misinformation — not safety concerns. But the timing speaks for itself: the discontinuation came after decades of litigation, billions in verdicts and settlements, three failed bankruptcy attempts, and the filing of over 68,000 federal cases. The product is gone from American shelves, but the liability for the decades it was sold remains.
The Medicine: Ovarian Cancer, Talc, and the Biological Mechanism
Ovarian cancer is one of the deadliest cancers that affects women. It is often called a “silent killer” because its symptoms — bloating, pelvic pain, urinary urgency, feeling full quickly — are vague and easily attributed to other conditions until the disease has progressed to an advanced stage. By the time most ovarian cancers are diagnosed, they have already spread beyond the ovaries.
The Alleged Mechanism: How Talc Is Theorized to Reach the Ovaries
The biological mechanism theory in talc-ovarian cancer cases describes a pathway that is biomechanically plausible even if not universally proven:
-
Application: Talc-based baby powder is applied to the perineal area — the region between the vagina and the anus — for feminine hygiene, as J&J marketed it for decades.
-
Migration: Talc particles — microscopic, lightweight, and designed to disperse — enter the vagina and travel upward through the cervix, into the uterus, and through the fallopian tubes to the ovaries. This pathway is anatomically real: the female reproductive tract provides a direct physical route from the external genitalia to the ovaries.
-
Inflammation: Talc particles that reach the ovaries are foreign bodies that the immune system cannot fully clear. They cause chronic inflammation — a sustained immune response that creates an environment of oxidative stress and cellular damage.
-
Carcinogenesis: Chronic inflammation is a recognized driver of cancer in multiple tissues. In the ovaries, the theory holds that years of talc-induced inflammation cause DNA damage in ovarian epithelial cells, eventually producing the malignant transformation that becomes ovarian cancer.
The Defense’s Alternative Causation Arguments
The defense counters with a list of alternative risk factors that are real and medically recognized:
- BRCA1 and BRCA2 mutations: Genetic mutations that dramatically increase ovarian cancer risk. But most ovarian cancer patients do not carry these mutations, and genetic testing can rule them in or out.
- Family history: A family history of ovarian or breast cancer increases risk. But family history alone does not explain most cases.
- Nulliparity: Women who have never given birth have a higher risk. But many ovarian cancer patients had children.
- Endometriosis: This condition increases risk. But it is not present in most cases.
- Hormone replacement therapy: Long-term use increases risk. But many patients never used it.
- Age: Ovarian cancer risk increases with age. But age is a risk factor for virtually all cancers — it does not explain why one woman gets ovarian cancer and another does not.
- Obesity: Elevated risk. But many ovarian cancer patients were not obese.
The defense strategy is to list every possible alternative cause and argue that the plaintiff cannot exclude all of them. The plaintiff’s counter is that the presence of one or more alternative risk factors does not exclude talc as a contributing cause — and that the exposure history (decades of daily perineal talc use, as marketed by J&J) is the distinguishing factor that makes talc the more likely explanation.
Treatment and the Human Cost
Ovarian cancer treatment typically involves surgical debulking — removal of the ovaries, fallopian tubes, uterus, and often surrounding tissue — followed by chemotherapy, usually a combination of carboplatin and paclitaxel. Many patients require multiple rounds of chemotherapy as the cancer recurs. Targeted therapies, immunotherapy, and PARP inhibitors may extend survival but are not cures. The five-year survival rate for advanced-stage ovarian cancer is roughly 30-40% — meaning the majority of women diagnosed at Stage III or IV will not survive five years.
The medical trajectory of fatal ovarian cancer — the surgery, the chemotherapy, the hair loss, the nausea, the fatigue, the scan waiting, the recurrence, the second-line treatment, the decline, the hospice, the death — is the survival-action damages story. It is what the decedent endured between injury and death, and in California, it is compensable.
What Compensation Looks Like in a Talc Wrongful Death Case
California provides two parallel damage tracks after a fatal injury, and both are available in talc-ovarian cancer cases.
Wrongful Death Damages
Wrongful death damages compensate the surviving family for what they lost. In California, wrongful death damages include:
- Economic losses: The decedent’s anticipated financial support to the family, funeral and burial expenses, and the value of household services the decedent would have provided (childcare, cooking, home maintenance, management of the household — valued using federal time-use data and market replacement costs).
- Non-economic losses: Loss of love, companionship, comfort, care, assistance, protection, affection, society, moral support, and guidance. These are the human losses — the empty chair at the table, the voice that does not answer the phone, the grandmother who will not see her grandchildren grow up. There is no statutory cap on these damages in California product liability cases.
Survival Damages
Survival damages capture what the decedent lost between injury and death. In California, survival damages include:
- Pre-death pain and suffering: The physical pain, emotional distress, and loss of enjoyment of life the decedent experienced between the cancer diagnosis and death — the surgery, the chemotherapy, the fear, the decline. California has recently expanded what survival actions can recover in this category, and recent legislative amendments have altered the landscape — the current rule should be confirmed for your specific case.
- Medical expenses: The cost of all cancer treatment between diagnosis and death.
- Lost earnings: Income the decedent lost between diagnosis and death.
Punitive Damages
Under California Civil Code § 3294, punitive damages are available upon a showing of malice, oppression, or fraud by clear and convincing evidence. In the talc context, punitive damages theory relies on evidence that J&J:
- Knew of the epidemiological association between perineal talc use and ovarian cancer for decades
- Continued to market baby powder specifically for feminine hygiene use despite that knowledge
- Failed to include adequate warnings on the product label
- Concealed or downplayed internal scientific concerns about talc safety
- Continued to defend the product’s safety publicly while internally debating warning language
If proven, punitive damages are uncapped in California product liability cases. There is no statutory ceiling.
Case Value Range
The two California bellwethers establish the realistic range for this coordinated proceeding:
- Low end: $0 (defense verdict, as occurred in this second bellwether)
- High end: $40 million+ (as demonstrated by the first California bellwether)
Nationally, talc-ovarian cancer verdicts have ranged from defense outcomes to the Ingham multi-plaintiff verdict (originally $4.69 billion, reduced to approximately $2.12 billion, affirmed by the U.S. Supreme Court’s denial of certiorari in June 2021). Individual case value depends on case-specific factors: length and frequency of talc use, decedent age and health history, alternative ovarian cancer risk factors, the strength of internal corporate documents showing J&J’s knowledge, whether preserved tumor tissue is available for mineral analysis, and the quality of specific causation expert testimony.
The extreme variance — from zero to $40 million in the same courthouse system — reflects the central causation battleground. A case with strong specific causation evidence (decades of daily use, no significant alternative risk factors, mineral analysis showing talc in ovarian tissue) sits at the high end. A case with weak specific causation (short duration of use, multiple alternative risk factors, no preserved tissue) sits at the low end.
Evidence Preservation: The Clock Is Already Running
In a mass tort case involving a product that was used decades ago and a disease that developed over years, the evidence is fragile and perishable. Every day you wait, proof disappears. Here is what exists, who holds it, and how fast it can legally die.
Decedent Medical Records — HIGH URGENCY
Pathology reports, tumor slides, and tissue blocks are the single most important evidence for specific causation. If preserved tumor tissue exists, a mineralogist can perform mineral analysis to detect talc particles embedded in the ovarian tissue — direct physical proof that talc reached the target organ.
Who holds it: The hospital or pathology laboratory that performed the surgery or biopsy.
How fast it dies: Hospital retention policies vary. Some institutions retain tissue blocks for 10+ years; others may dispose of them sooner. Once tissue blocks are destroyed, they cannot be recreated. This is the highest-priority preservation target. A preservation letter must go to the pathology department immediately.
Decedent Talc-Use History — HIGH URGENCY
Purchase records, product containers, and family witness testimony establish the exposure dose and duration necessary for specific causation expert testimony. Product containers can be physically tested for talc composition and asbestos contamination.
Who holds it: Family members (memories, product containers in the home), retailers (purchase records, loyalty-program data).
How fast it dies: Family member memories fade. Product containers may be discarded during estate cleanup or moving. Purchase records may be subject to retailer data-retention limitations. Every month that passes, the specificity of “she used it every day after her shower for 30 years” becomes harder to prove with corroboration.
Internal J&J Corporate Documents — MODERATE URGENCY
Testing records, safety analyses, scientific correspondence regarding talc and asbestos contamination, internal debates about warning language, and marketing decisions to promote feminine hygiene use despite internal scientific concern.
Who holds it: Johnson & Johnson.
How fast it dies: In active litigation, litigation holds prevent destruction. But these documents are accessible only through discovery — which requires a filed lawsuit. The sooner a case is filed, the sooner the discovery process can lock down these documents.
J&J Marketing and Advertising Materials — LOWER URGENCY
Historical advertising campaigns targeting women for feminine hygiene use of baby powder demonstrate the foreseeable use pathway central to design defect and failure-to-warn theories.
Who holds it: J&J corporate archives, regulatory submissions, advertising industry archives.
How fast it dies: Archival advertising materials are typically preserved through litigation holds and regulatory submissions, but historical campaigns may require expert archival research.
Epidemiological and Toxicological Literature — LOW URGENCY
Published scientific studies on talc and ovarian cancer, IARC monographs, and meta-analyses are the foundation for general causation expert testimony.
Who holds it: Publicly available scientific journals and databases.
How fast it dies: Published scientific literature is permanently available, but evolving meta-analyses and new studies may shift the causation landscape over time.
FDA and Regulatory Correspondence — MODERATE URGENCY
Communications between J&J and the FDA regarding talc safety, testing, and labeling establish regulatory history and J&J’s awareness of governmental scrutiny.
Who holds it: FDA (obtainable through FOIA), J&J corporate records.
How fast it dies: Agency records are subject to FOIA retrieval but processing timelines can delay access.
The Defense Playbook: What J&J’s Lawyers Do at Trial
Johnson & Johnson’s defense team is among the most sophisticated in the world. The defense verdict in the second bellwether was not an accident — it was the product of a deliberate strategy. Here are the plays they run and how to counter each one.
Play 1: “The Science Is Unsettled”
The defense presents the epidemiological evidence as a “debate” rather than a body of research showing a consistent association. They emphasize studies that found no link, downplay studies that did, and argue that the absence of a universally accepted biological mechanism means causation has not been proven.
The counter: The epidemiological literature spanning decades shows a consistent association between perineal talc use and ovarian cancer, particularly with long-term, frequent use. The absence of a single, universally accepted biological mechanism is not the same as the absence of any biological mechanism — multiple plausible pathways have been proposed and studied. And the consumer-expectation test under Barker does not require proof of mechanism: it asks whether an ordinary consumer would expect a product marketed for feminine hygiene to cause ovarian cancer. The answer is no — and that is enough.
Play 2: “Alternative Risk Factors Caused This Cancer”
The defense lists every alternative ovarian cancer risk factor the decedent had — age, family history, reproductive history, hormone use, obesity — and argues that the plaintiff cannot prove talc caused the cancer rather than these other factors.
The counter: A specific causation expert — a gynecologic oncologist or epidemiologist — can perform a differential diagnosis: systematically evaluating each alternative risk factor, ruling out those that do not apply to this decedent, and concluding that talc is the most likely cause given the exposure history. The presence of one or more alternative risk factors does not exclude talc as a cause; cancer causation is multifactorial, and a defendant who created a known risk factor is responsible even if other risk factors contributed.
Play 3: “The Statute of Limitations Has Expired”
The defense argues that the plaintiff knew or should have known about the talc-ovarian cancer link years before filing and that the statute of limitations has run.
The counter: California’s discovery rule starts the clock when the plaintiff knew or reasonably should have known of the injury and its cause. For many women, the connection between baby powder and ovarian cancer was not something they knew or should have known until media coverage, litigation reporting, or their attorney informed them. The discovery rule is a factual question, often for the jury — and a well-pleaded case with a clear timeline can defeat a limitations defense.
Play 4: “We Stopped Selling Talc Powder — The Problem Is Solved”
The defense points to the 2023 discontinuation of talc-based baby powder in North America and argues that the company has already addressed the concern.
The counter: Discontinuing a product does not erase decades of liability for injuries caused while it was on the market. The product was sold for over a century. The women who developed ovarian cancer from long-term use were exposed long before the discontinuation. Cessation of sales is not a remedy for past harm — it is a business decision made after 68,000 lawsuits and three failed bankruptcy attempts.
Play 5: “J&J Acted Responsibly Under the Regulatory Framework”
The defense argues that J&J complied with all applicable FDA regulations, that no federal warning was required, and that the company acted within the bounds of the regulatory system.
The counter: Compliance with an absent regulatory standard is not proof of safety. The FDA never reviewed talc for carcinogenicity from perineal use. The FDA never required a warning. The regulatory gap is not a defense — it is the reason the product stayed on the market without warnings for as long as it did. California strict products liability does not require a regulatory violation; it requires a defective product that caused injury.
How a Talc Case Is Actually Built
Here is the chronological walk of how a talc-ovarian cancer wrongful death case is constructed, from the first call through resolution.
Week One — Preservation: The day you call, the preservation letters go out. To the pathology department: preserve all tissue blocks, slides, and pathology reports. To J&J (once a case is filed): preserve all internal documents relating to talc safety, testing, marketing, and warnings. To any retailer whose loyalty program may have tracked talc purchases: preserve the purchase history. The goal is to freeze every piece of evidence before it legally disappears.
Weeks One Through Four — Records Assembly: We pull the complete medical record — the diagnosis, the pathology, the treatment history, the surgical records, the chemotherapy records, the imaging, the final hospitalization. We gather the decedent’s talc-use history through family interviews: which product, how often, how long, for what purpose. We identify and preserve any physical product containers.
Months One Through Three — Expert Selection and Causation Analysis: We retain a gynecologic oncologist to perform a specific causation analysis — reviewing the decedent’s medical history, ruling out alternative causes, and opining that talc was the most likely cause of the cancer. If preserved tissue exists, we retain a mineralogist to perform mineral analysis on the ovarian tissue. We retain an epidemiologist to anchor the general causation opinion in the published literature. Every expert must be selected with California’s Sargon gatekeeping standard in mind — their methodology must be sound, their reasoning must be clear, and their opinions must be tethered to the record.
Months Three Through Six — Corporate Discovery: Once a case is filed and discovery opens, we demand the internal J&J documents: testing records showing what the company knew about talc and asbestos contamination; internal scientific correspondence debating the carcinogenicity risk; marketing materials promoting feminine hygiene use; internal debates about warning language; and the timeline of when J&J knew what. These documents are the spine of the failure-to-warn and punitive damages theories.
Months Six Through Twelve — Depositions: The corporate witnesses — the scientists who tested the talc, the executives who approved the marketing, the regulatory affairs staff who communicated with the FDA — are deposed under oath. The defense experts are deposed. The plaintiffs’ experts are deposed. The deposition record is where the defense’s arguments are tested and where the plaintiff’s case is strengthened or exposed.
Year One Through Resolution — Trial or Settlement: The case proceeds toward trial or settlement. In the coordinated proceeding, bellwether selection determines which cases go first. The strength of the specific causation evidence — the exposure history, the alternative-risk-factor analysis, the tissue mineral analysis if available — is the primary driver of case value and settlement leverage.
Your First Steps: What to Do Now
If you lost a loved one to ovarian cancer and she used Johnson & Johnson baby powder for feminine hygiene over a period of years, here is what you should do — and what you should not do.
Do: Write down everything you know about her talc use. Which product — was it J&J baby powder specifically? How often did she use it — daily, weekly? How many years — ten, twenty, thirty? For what purpose — feminine hygiene, as the product was marketed? Where did she keep it — the bathroom, the bedroom? Does anyone else in the family know about her use? Do any product containers still exist? This information is the foundation of the exposure evidence, and it fades with time.
Do: Locate her medical records, particularly the pathology records. If she had surgery for ovarian cancer, the pathology department at the hospital may still have tissue blocks and slides preserved. These are the single most valuable pieces of evidence in a talc case because they can be physically tested for talc particles. Find out where her surgery was performed and whether the pathology materials still exist.
Do: Note the date she was diagnosed with ovarian cancer and the date of her death. These dates matter for the statute of limitations. Note when you first learned of a possible connection between talc and ovarian cancer — that date may be the start of the discovery-rule clock.
Do not: Assume you are too late. The discovery rule in California may mean your clock started much later than you think. But do not use that as a reason to wait — the evidence is dying, and the clock is real.
Do not: Contact Johnson & Johnson or their representatives. Anything you say to the company or its claims administrators can and will be used against your case. Let your lawyer do the talking.
Do not: Sign anything from any insurance company, claims administrator, or J&J representative. No release, no authorization, no settlement offer — nothing. A quick check with a release attached is one of the oldest plays in the book, and in a mass tort context, the company may offer a modest “resolution payment” that waives your right to pursue the full value of your claim.
Do not: Post about talc, ovarian cancer, or your potential claim on social media. The defense monitors social media for evidence to use against plaintiffs — statements about the decedent’s other risk factors, statements about when you first learned of the talc-cancer link, anything that can be taken out of context.
Frequently Asked Questions
Does the defense verdict mean the science linking talc to ovarian cancer was rejected?
No. A defense verdict means that one specific jury, hearing one specific set of three cases, was not persuaded to the required burden of proof that talc caused those three women’s cancer. It does not reject the scientific literature, the epidemiological association, or the biological mechanism theories. In the first California bellwether, a different jury was persuaded — and returned a $40 million verdict. The science is the same; the specific causation presentation is what differed.
Can I still file a talc-ovarian cancer claim after this defense verdict?
Yes. The defense verdict does not bar any other plaintiff from filing or pursuing a claim. Each case is individual. Your case has its own exposure history, its own medical record, its own pathology, its own causation evidence. If your loved one used J&J baby powder for decades and developed ovarian cancer, your case may be stronger than the cases that produced the defense verdict — or it may face different challenges. The only way to know is to have the case evaluated.
How long do I have to file a talc wrongful death claim in California?
California’s statute of limitations for wrongful death generally runs two years from the date of death under Code of Civil Procedure § 335.1. However, the discovery rule may delay the start of the clock for the underlying product liability claim until the plaintiff knew or reasonably should have known of the injury and its cause. The specific accrual date is case-specific and should be evaluated by an attorney immediately. Do not assume you have plenty of time, and do not assume you are too late — call and find out.
What if my loved one’s ovarian cancer had other risk factors — can I still have a case?
Yes. The presence of alternative risk factors (age, family history, reproductive history, etc.) does not automatically defeat a talc claim. Cancer causation is multifactorial — multiple causes can contribute. A specific causation expert can perform a differential diagnosis, evaluating each risk factor and opining whether talc was a substantial contributing cause. The defense will argue alternative causes, but the plaintiff’s expert counters with the exposure history and the differential analysis. This is the specific causation battleground — and it is winnable.
What if the pathology tissue is no longer available?
If the hospital has destroyed the tissue blocks and slides, mineral analysis cannot be performed — but the case is not necessarily dead. Specific causation can still be established through the exposure history (decades of daily perineal talc use), the differential diagnosis (ruling out alternative causes), and the epidemiological literature (showing that long-term talc use significantly increases ovarian cancer risk). Tissue mineral analysis is the strongest specific causation evidence, but it is not the only evidence. This is why preserving the pathology materials immediately is so urgent — but even without them, a strong case can be built.
Is there a cap on damages in California talc cases?
No. California’s MICRA cap on non-economic damages applies only to medical malpractice cases. Product liability cases — including talc-ovarian cancer wrongful death claims — are not subject to MICRA. There is no statutory cap on non-economic damages (pain, suffering, loss of companionship) or punitive damages in California product liability cases. A jury can award what the evidence supports, without a statutory ceiling.
What is the difference between the California state-court cases and the federal MDL?
The federal MDL (MDL-2738) consolidates federal talc cases in the U.S. District Court for the District of New Jersey before Judge Michael A. Shipp. The California coordinated proceeding consolidates state-court talc cases in Los Angeles County Superior Court. Both involve the same product, the same defendant, and the same basic claims. The bellwether trials discussed on this page are from the California state-court coordinated proceeding. A plaintiff’s case may be in either system depending on where it was filed and the parties involved.
What if J&J files for bankruptcy again?
J&J has tried three times to use bankruptcy to wall off talc liability — through LTL Management LLC (twice) and Red River Talc LLC (once). All three attempts were dismissed by the bankruptcy courts. While the company may try again, each failed attempt makes the next one harder. As of now, the cases are in the tort system, where juries decide outcomes — not bankruptcy judges. If a future bankruptcy filing occurs, it may temporarily pause litigation but does not eliminate claims.
How much is my talc-ovarian cancer case worth?
Case value depends on case-specific factors: the length and frequency of talc use, the decedent’s alternative risk factors, whether preserved tissue is available for mineral analysis, the strength of internal J&J documents, and the quality of specific causation expert testimony. The two California bellwethers establish the realistic range: $0 (defense verdict) to $40 million (first bellwether). Nationally, the affirmed Ingham verdict stands at approximately $2.12 billion for 22 plaintiffs. An honest evaluation requires reviewing the specific facts of your case — and an honest attorney will tell you that no outcome is guaranteed. Past results depend on the facts of each case and do not guarantee future outcomes.
Does it matter that J&J stopped selling talc baby powder?
The 2023 discontinuation of talc-based baby powder in North America does not affect liability for injuries caused while the product was on the market. The product was sold for over a century. The women who developed ovarian cancer from long-term use were exposed long before the discontinuation. Stopping sales is not a legal defense — it is a business decision. The liability remains.
Why Attorney911
We are a trial firm that takes California product liability and wrongful death cases, and we approach talc litigation with the specific tools it demands: the regulatory expertise to explain the FDA gap, the medical knowledge to build specific causation, the corporate-structure analysis to identify the right defendant, and the trial experience to present it all to a jury.
Ralph Manginello has spent 27+ years in courtrooms, including federal court. A journalist before he was a lawyer, he approaches every case with an investigator’s instinct for the document that changes everything — the internal memo, the test result, the marketing decision that shows what the company knew and when. He is admitted to the U.S. District Court for the Southern District of Texas and takes California cases working with local counsel where required.
Lupe Peña spent years inside a national insurance-defense firm — the rooms where claims like yours are priced, devalued, and denied. He knows how the other side values a case, how it selects its experts, how it builds its defense playbook, and how it uses delay and doubt to wear families down. He now uses that inside knowledge for injured clients. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter.
We work on contingency. That means: free consultation, no fee unless we win your case. If we do not recover money for you, you owe us no attorney’s fees. If we do, our fee is a percentage of the recovery — 33.33% before trial, 40% if the case goes to trial. We do not get paid unless you get paid.
We are available 24/7 with live staff — not an answering service. Contact us at 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation. The call costs nothing. The information is worth everything.
Hablamos Español. Lupe conducts full consultations in Spanish, and our staff is bilingual. If your family communicates in Spanish, we will meet you in your language.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Every case is different. The only way to know what your case is worth is to talk to a lawyer who can evaluate your specific facts — and the only way to preserve your evidence is to do it before the clock and the shredder catch up.
The defense verdict in the second California bellwether is not the end of talc litigation. It is a lesson in what specific causation requires — and a reminder that the difference between a $40 million verdict and a defense verdict is often the quality of the proof, not the strength of the science. If your family’s story includes decades of baby powder and a diagnosis that came too late, call us. The evidence is waiting. The clock is running. And the company that marketed this product to women for a century is counting on you not to pick up the phone.
1-888-ATTY-911. Free consultation. No fee unless we win.